Literature DB >> 27908257

Ginkgo biloba as an Alternative Medicine in the Treatment of Anxiety in Dementia and other Psychiatric Disorders.

Sandeep Kumar Singh1, George E Barreto2, Gjumrakch Aliev3, Valentina Echeverria4.   

Abstract

BACKGROUND: Mental disorders are the most common health problems in the worldwide population. Current medicines against these conditions have undesired side effects or limited effectiveness. These disadvantageous pharmacological and therapeutic characteristics provoke a low adherence to treatment in an important percentage of patients with mental disorders. Since ancient times, ethnically different groups have been using plants extracts as medicines for the treatment of mental conditions including dementia, depression and anxiety disorders. Among them are extracts of Ginkgo biloba, a tree in the division Gingophyta, that has been used by millions of people worldwide.
OBJECTIVE: This review aims to discuss current scientific evidence of efficacy, neuroprotective and antioxidant effects as mechanism of action, side effects and potential interaction with other commonly prescribed anxiolytic drugs.
METHODS: A PubMed search of preclinical studies as well as individual clinical trials and meta-analysis were scrutinized.
RESULTS: Various preclinical and clinical studies have shown a positive effect of Ginkgo biloba to improve cognitive abilities in impaired individuals and reducing anxiety under pathological conditions.
CONCLUSION: A more advanced clinical research is needed to confirm the efficacy of Gingko biloba for the treatment of anxiety in different health conditions. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer; Anxiety; medicinal plants; neurodegeneration; neuroinflammation; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 27908257     DOI: 10.2174/1389200217666161201112206

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  13 in total

1.  Inhibiting Effect of Zinc Oxide Nanoparticles on Advanced Glycation Products and Oxidative Modifications: a Potential Tool to Counteract Oxidative Stress in Neurodegenerative Diseases.

Authors:  Jalaluddin M Ashraf; Mohammad Azam Ansari; Sana Fatma; Saleh M S Abdullah; Johar Iqbal; Aymen Madkhali; Al Hassan Hamali; Saheem Ahmad; Ahmed Jerah; Valentina Echeverria; George E Barreto; Ghulam Md Ashraf
Journal:  Mol Neurobiol       Date:  2018-02-08       Impact factor: 5.590

2.  In Silico Identification of Novel Interactions for FABP5 (Fatty Acid-Binding Protein 5) with Nutraceuticals: Possible Repurposing Approach.

Authors:  Ricardo Cabezas; Amirhossein Sahebkar; Valentina Echeverria; Janneth González Santos; Ghulam Md Ashraf; George E Barreto
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Ginkgo biloba extracts inhibit post-ischemic LTP through attenuating EPSCs in rat hippocampus.

Authors:  Yong Liu; Supeng Ding; Yifei Luan; Zhichao Zhu; Yuting Cai; Yingkui Liu
Journal:  Metab Brain Dis       Date:  2021-08-31       Impact factor: 3.584

Review 4.  Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review.

Authors:  Eva-Maria Pferschy-Wenzig; Manuela R Pausan; Karin Ardjomand-Woelkart; Stefanie Röck; Ramy M Ammar; Olaf Kelber; Christine Moissl-Eichinger; Rudolf Bauer
Journal:  Nutrients       Date:  2022-05-18       Impact factor: 6.706

Review 5.  Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders.

Authors:  Sandeep Kumar Singh; Saurabh Srivastav; Rudolph J Castellani; Germán Plascencia-Villa; George Perry
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

6.  Efficacy and safety of ginkgo preparations for attention deficit hyperactivity disorder: a systematic review protocol.

Authors:  Sufei He; Miao Wang; Jinhua Si; Tianyi Zhang; Hong Cui; Xiumei Gao
Journal:  BMJ Open       Date:  2018-02-20       Impact factor: 2.692

7.  The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.

Authors:  Ai-Mei Zhao; Wen-Ran Qiu; Li-Jun Mao; Jun-Guo Ren; Li Xu; Ming-Jiang Yao; Kellie Bilinksi; Dennis Chang; Jian-Xun Liu
Journal:  Trials       Date:  2018-05-10       Impact factor: 2.279

Review 8.  Ginkgo biloba: A Treasure of Functional Phytochemicals with Multimedicinal Applications.

Authors:  Rajib Das; Mashia Subha Lami; Arka Jyoti Chakraborty; Saikat Mitra; Trina Ekawati Tallei; Rinaldi Idroes; Amany Abdel-Rahman Mohamed; Md Jamal Hossain; Kuldeep Dhama; Gomaa Mostafa-Hedeab; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-28       Impact factor: 2.629

9.  Therapeutic Effectiveness of Galphimia glauca in Young People with Social Anxiety Disorder: A Pilot Study.

Authors:  Ofelia Romero-Cerecero; Ana Laura Islas-Garduño; Alejandro Zamilpa; Ma Dolores Pérez-García; Jaime Tortoriello
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-27       Impact factor: 2.629

Review 10.  Neurophysiology and Psychopathology Underlying PTSD and Recent Insights into the PTSD Therapies-A Comprehensive Review.

Authors:  Gjumrakch Aliev; Narasimha M Beeraka; Vladimir N Nikolenko; Andrey A Svistunov; Tatyana Rozhnova; Svetlana Kostyuk; Igor Cherkesov; Liliya V Gavryushova; Andrey A Chekhonatsky; Liudmila M Mikhaleva; Siva G Somasundaram; Marco F Avila-Rodriguez; Cecil E Kirkland
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.